Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Virology Specimen Collection Market, by Sample
1.4.2 North America Virology Specimen Collection Market, by Product Type
1.4.3 North America Virology Specimen Collection Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Virology Specimen Collection Market by Sample
3.1 North America Nasopharyngeal Samples Market by Country
3.2 North America Throat Samples Market by Country
3.3 North America Cervical Samples Market by Country
3.4 North America Nasal Samples Market by Country
3.5 North America Blood Samples Market by Country
3.6 North America Oral Samples Market by Country
3.7 North America Other Samples Market by Country
Chapter 4. North America Virology Specimen Collection Market by Product Type
4.1 North America Viral Transport Media Market by Country
4.2 North America Specimen Collection Tubes Market by Country
4.3 North America Blood Collection Kits Market by Country
4.4 North America Swabs Market by Country
Chapter 5. North America Virology Specimen Collection Market by Country
5.1 US Virology Specimen Collection Market
5.1.1 US Virology Specimen Collection Market by Sample
5.1.2 US Virology Specimen Collection Market by Product Type
5.2 Canada Virology Specimen Collection Market
5.2.1 Canada Virology Specimen Collection Market by Sample
5.2.2 Canada Virology Specimen Collection Market by Product Type
5.3 Mexico Virology Specimen Collection Market
5.3.1 Mexico Virology Specimen Collection Market by Sample
5.3.2 Mexico Virology Specimen Collection Market by Product Type
5.4 Rest of North America Virology Specimen Collection Market
5.4.1 Rest of North America Virology Specimen Collection Market by Sample
5.4.2 Rest of North America Virology Specimen Collection Market by Product Type
Chapter 6. Company Profiles
6.1 Trinity Biotech Plc
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.2 Thermo Fisher Scientific, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Becton, Dickinson and Company
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.4 DiaSorin S.p.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Vircell S.L.
6.5.1 Company Overview
6.6 Quidel Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Approvals and Trials:
6.7 Titan Biotech Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.8 Puritan Medical Products
6.8.1 Company Overview
6.9 Copan Italia s.p.a.
6.9.1 Company Overview
6.1 Hardy Diagnostics
6.10.1 Company Overview
Unique Offerings 